• 1. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 2. An atom-economical protocol for direct conversion of Baylis–Hillman alcohols to β-chloro aldehydes in water?
  Raktani Bikshapathi,Sai Prathima Parvathaneni,Vaidya Jayathirtha Rao Green Chem., 2017,19, 4446-4450
• 3. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin
• 4. An ionic liquid promoted microwave-hydrothermal route towards highly photoluminescent carbon dots for sensitive and selective detection of iron(iii)?
  Ruili Liu,Mengping Gao,Jing Zhang,Zhilian Li,Jinyang Chen,Ping Liu,Dongqing Wu RSC Adv., 2015,5, 24205-24209
• 5. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acid esters
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzoic acid esters

Recent Advances in the Study of Methyl 3-Thiazol-2-yl-benzoate (CAS: 168618-63-1) and Its Applications in Chemical Biology and Medicine

Methyl 3-Thiazol-2-yl-benzoate (CAS: 168618-63-1) is a chemical compound that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its thiazole and benzoate functional groups, has been explored for its role in drug discovery, particularly in the development of novel therapeutic agents. Recent studies have highlighted its utility as a building block in the synthesis of biologically active molecules, including kinase inhibitors and antimicrobial agents.

One of the key areas of research involving Methyl 3-Thiazol-2-yl-benzoate is its application in the design of kinase inhibitors. Kinases play a critical role in cellular signaling pathways, and their dysregulation is often associated with diseases such as cancer and inflammatory disorders. Recent publications have demonstrated that derivatives of Methyl 3-Thiazol-2-yl-benzoate exhibit potent inhibitory activity against specific kinases, making them promising candidates for further drug development. For instance, a 2023 study published in the Journal of Medicinal Chemistry reported the synthesis and evaluation of a series of thiazole-containing compounds, including Methyl 3-Thiazol-2-yl-benzoate derivatives, which showed selective inhibition of certain cancer-related kinases.

In addition to its role in kinase inhibition, Methyl 3-Thiazol-2-yl-benzoate has also been investigated for its antimicrobial properties. A recent study in the European Journal of Medicinal Chemistry (2024) explored the compound's efficacy against a range of bacterial and fungal pathogens. The researchers synthesized several analogs of Methyl 3-Thiazol-2-yl-benzoate and evaluated their antimicrobial activity, revealing that certain derivatives exhibited broad-spectrum activity with minimal cytotoxicity. These findings suggest that this compound could serve as a valuable scaffold for the development of new antimicrobial agents, particularly in the face of rising antibiotic resistance.

The synthetic versatility of Methyl 3-Thiazol-2-yl-benzoate has also been a focus of recent research. Advances in organic chemistry methodologies have enabled the efficient modification of this compound to produce diverse derivatives with tailored biological activities. For example, a 2024 study in Organic Letters detailed a novel catalytic approach to functionalize the thiazole ring of Methyl 3-Thiazol-2-yl-benzoate, opening new avenues for the creation of structurally complex and pharmacologically relevant molecules. Such innovations underscore the compound's potential as a key intermediate in medicinal chemistry.

Despite these promising developments, challenges remain in the optimization of Methyl 3-Thiazol-2-yl-benzoate-based compounds for clinical use. Issues such as bioavailability, metabolic stability, and off-target effects need to be addressed through further preclinical studies. However, the growing body of research on this compound and its derivatives highlights its significance in the field of chemical biology and drug discovery. Future studies are expected to explore its applications in other therapeutic areas, such as neurodegenerative diseases and metabolic disorders, further expanding its potential impact.

In conclusion, Methyl 3-Thiazol-2-yl-benzoate (CAS: 168618-63-1) represents a versatile and promising compound in the realm of chemical biology and pharmaceutical research. Its applications in kinase inhibition, antimicrobial activity, and synthetic chemistry demonstrate its broad utility and potential for contributing to the development of novel therapeutics. As research continues to uncover new insights into its properties and mechanisms of action, this compound is likely to remain a focal point of scientific investigation in the years to come.

• 473538-10-2(Methyl 3-[4-(hydroxymethyl)-1,3-thiazol-2-yl]benzoate)
• 2182-77-6(Benzoic acid, 4-(2-benzothiazolyl)-, methyl ester)
• 184847-97-0(3-(1,3-thiazol-2-yl)phenylmethanol)
• 266369-49-7(4-(Thiazol-2-yl)benzoic acid)
• 454678-91-2((4-Thiazol-2-yl-phenyl)-methanol)
• 257876-04-3(4-Thiazol-2-yl-benzoic acid ethyl ester)
• 35195-86-9(3-(4-methyl-1,3-thiazol-2-yl)benzoic acid)
• 847956-27-8(3-(1,3-Thiazol-2-yl)benzoic acid)
• 305806-42-2(Methyl 4-(thiazol-2-Yl)benzoate)
• 886851-29-2(Ethyl 3-(1,3-thiazol-2-yl)benzoate)